| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . 490 . 500 . 510 . 520 . 530 . 540 . 550 . 560 . 570 . 580 . 590 . 600 . 610 . 620 . 630 . 640 . 650 . 660 . 670 . 680 . 690 . 700 . 710 . 720 . 730 . 740 . 750 . 760 . 770 . 780 . 790 . 800 . 810 . 820 . 830 . 840 . 850 . 860 . 870 . 880 . 890 . 900 . 910 . 920 . 930 . 940 . 950 . 960 . 970 . 980 . 990 . 1000 . 1010 . 1020 . 1030 . 1040 . 1050 . 1060 . 1070 . 1080 . 1090 . 1100 . 1110 |
| # |
Score |
Template |
Links and tools | %id | First |
IYGPNEAGKTTTMEAALRLFYGFPLREAYAFKHQRNNLQVSATFDIEGAARRFTRLPKRIGSLVDETGTALPEAALSAHLAGLSEGDYRQLLCLDDETIERGGEEIANAQGDIGRLLFSAAAGVADLSGVLDGVRDEANSIWKKRGRTTRIAELKHALADVEKEIREKDVTAGAWKGLKKALTQAQEYEQAARKSRDVLNISKAQIAGQQRALPLMAEISTLEKSTATYSEYPDQLDFDPERLIELRTDHGTASQNIERLTMEITALKNELDEITLDKEQLELAVQLDALHDLSVRNRSAQLDLQRRQVEKDVAEEAMSSAALDLGVSPKADLQDLVLSQADISKLETAKEELRDAIASVANESREVADLKKKLEAAGDAVETNTGDTDDSPSISDVLVRFDVDRLAPAHAAALQAIGAAKTKARKALSALTFGTVVFEDVPTGVSSMIQAQSWAAEHEKISQTIHNTIDKRDNHQEDLATRIAQGKVLTAGGAVVTDAETEVLLTAREDLWAEHQAALESQTASAFYEAMQKHDKAMDARVTHASELGQLRQIEQAEVEAQIRLEQADKRLEVLDKELTALDAAVGAAARQAGLTSTITSAEWLDWVARNSTATEDAQALFAAREEHQPILDRAEDLRAELSRLLTFEATDVASALTVARQVAEGERKQSENEARAQETLQQAKRNLRKREERHQAALSVEAEARNAWYTLILEMLGDRIAPENLQASLEPLRELREHAKTRASAAQRVASMKVDQERFAEEVAALAKAYNLETLETAAETFSALKTLSDRARSAHEAVEKLTGDIKEAEARKSKNSEKLREIKQAIEAIASGFPYSTSLTEIDELRTVVKRAQQVIEERAALVKLQRTVVSELGVNDIKAAREEMAALSLTDLEAAFENSKSDLERAEEELTQAIEIRVAAEQGVAQVTGDADIATLVEQKATLELQLEDSALEHLELSLGHYLASNSIRRYRDSHRSGMMTATERCFASLTQGAYPSLITQVDKDAEVLLAVDCTGASKRAAEMSKGTRFQLYLALRAAAHEQLVAQGTRLPFFCDDIFETFDEDRTSAACRVMETIGSRGQAIYLTHHRHVVDIAMKVCDTPPVIHEI | Last |
| 1 | -209.000 | PF13514.1; B5J9R5_9RHOB/33-1144; AAA domain |
ali |
100 | 1 | IYGPNEAGKTTTMEAALRLFYGFPLREAYAFKHQRNNLQVSATFDIEGAARRFTRLPKRIGSLVDETGTALPEAALSAHLAGLSEGDYRQLLCLDDETIERGGEEIANAQGDIGRLLFSAAAGVADLSGVLDGVRDEANSIWKKRGRTTRIAELKHALADVEKEIREKDVTAGAWKGLKKALTQAQEYEQAARKSRDVLNISKAQIAGQQRALPLMAEISTLEKSTATYSEYPDQLDFDPERLIELRTDHGTASQNIERLTMEITALKNELDEITLDKEQLELAVQLDALHDLSVRNRSAQLDLQRRQVEKDVAEEAMSSAALDLGVSPKADLQDLVLSQADISKLETAKEELRDAIASVANESREVADLKKKLEAAGDAVETNTGDTDDSPSISDVLVRFDVDRLAPAHAAALQAIGAAKTKARKALSALTFGTVVFEDVPTGVSSMIQAQSWAAEHEKISQTIHNTIDKRDNHQEDLATRIAQGKVLTAGGAVVTDAETEVLLTAREDLWAEHQAALESQTASAFYEAMQKHDKAMDARVTHASELGQLRQIEQAEVEAQIRLEQADKRLEVLDKELTALDAAVGAAARQAGLTSTITSAEWLDWVARNSTATEDAQALFAAREEHQPILDRAEDLRAELSRLLTFEATDVASALTVARQVAEGERKQSENEARAQETLQQAKRNLRKREERHQAALSVEAEARNAWYTLILEMLGDRIAPENLQASLEPLRELREHAKTRASAAQRVASMKVDQERFAEEVAALAKAYNLETLETAAETFSALKTLSDRARSAHEAVEKLTGDIKEAEARKSKNSEKLREIKQAIEAIASGFPYSTSLTEIDELRTVVKRAQQVIEERAALVKLQRTVVSELGVNDIKAAREEMAALSLTDLEAAFENSKSDLERAEEELTQAIEIRVAAEQGVAQVTGDADIATLVEQKATLELQLEDSALEHLELSLGHYLASNSIRRYRDSHRSGMMTATERCFASLTQGAYPSLITQVDKDAEVLLAVDCTGASKRAAEMSKGTRFQLYLALRAAAHEQLVAQGTRLPFFCDDIFETFDEDRTSAACRVMETIGSRGQAIYLTHHRHVVDIAMKVCDTPPVIHEI |
1112 |
| 2 | -47.000 | PF02463.14; SMC_BACSU/2-1172; RecF/RecN/SMC N terminal domain |
ali follow.. |
11 | 28 | VVGPNGSGKSNITDAIRDIIFGSDSRKRLNLAE-------DHFLPIDFHEVSVTRR-RSGESEFLINNQPCRLKDIIDLFSGLGKEAFS----ISQGKV----EEILSSKAEDRRSIFEEAAGVLKYKTRKKKAENKLFET---QDNLNRVEDILHELEGQVEPLKIQASIAKDYLEKKKELEHVE-DIEELHGKWSTLKEKVQMAKEEELAESSAIS-AKIEDTRDKIQALDESVDELQQVLLVTSEELEKLEGRKEVLKERKKNAVQNQEQLEEAIVQFQQKET-EELSKQEAVFETLQAEVKQLRAQVKEKQQALSLHNENVEEKIEQLKSDYFELLNSQASIRNELQLLDDQMSQSAVTLQRLADNNEKHLQERHDISARKAACETEFARIE----QEIHSQVGAYRDMQTKYEQKKRQYEKNESALYQAYQYVQQARSKKDMLETMQGDFSGFYQGVKEVLKAKERLGGIRGAVLELISTEQKYETAIEIALGASAQHVVTDDEQSARKAIQYLKQNITEDLKGANELAKLLKKKNNSLLGRSRELEDVTKRLAEMEEKTALLEQEVKTLKHSIQDMEKKLAD-------------------------LRETGEGLRLKQQDVKGQLYELQVAEKNINTHLELYDQEKSALSESDEERKVRKRKLEEELSAVSEKMKQLEEDIDRLTKQKQTQSSTKESLSNELTELKIAAAKKEQACKGEEDNLARLKELTETELALKEAKEDLSFLTSEMSSSTSGEEKLEEAA--------KHKLNDKTKTIELIALRRDQRIKLQHGLDTYERELKEMKRLYKQKTTLLKDE----------------------EVKLGRMEVELDNLLQYLREEYSLSFEGAKEKYQLETDPEEARKRVKLIKLAIEELGT-----------------NLGSIDEFERVNERYKFLSEQKEDLTEAKNTLFQVIEEMDEEMTKRFNDTFVQIRSHFDQVFRSLFGGGRAELRLTDPNDGVEIIAQPPGKKLQNLNLLSGGERALTAIALLFSILKV-----RPVPFVLDEVEAALDEANVFRFAQYLKKYSSDTQFIVITHRKGTMEEADVLYG........ |
1161 |
| 3 | -43.000 | PF12128.3; Q8EAA0_SHEON/1-1188; Protein of unknown function (DUF3584 topsan) |
ali follow.. |
9 | 21 | ICGTNASGKTTLQRLV--VFYG-TRDSFERWYLPHDSSYI----------YEYQKADGLLYQAVAGDGKGVNYRFIAK----LNTREYRAIIQNDRTLLSTGSNALCDGEEKLAKAVHSKEGKMETVKSMIAAILEEDGVNPPSSRLNPQRVEAWIRESQLIQGFEVIRPEFEKLEQEFNQLLSAEMRLSSLSRGYRNDESLEADRLEIQQ-----TLSKELNLKLRMLDD------EWKEVRDELNLDLSAAKGDVAKCEYELDAIEDQHGAFL-DANIEQAKADLDMLPNWRADMENLSERHKLQTEKHQDIEAAYNARRSKIGEQLNRELEGLHSEQDKQRE-KQREVARGDLDALEAQWRSQMDAGKASFSEQEYQFKLNAAELKLRVDGVTYTEEEKLN--LAIFDERIHRADEEQESCNAKVERLTSDERKLRAKRDQANE--ALRIASLRVNERQTALDELHHMLFPQSHTLEFLRKEAQGWEQSLGKVIAPELLHRTDLHPSVTGESDTVFGVNLDLKAIDVPEYAASEQELRIRLSKAEEALQSAQELQAEAESQLVAINGELDKLSRELTFARTAYKNSRDDLRRLFDEKRSEQDKINKALAERKAFQQRLTQLDGELKQLKHQHQLWLEEQKEQALEARMEKQAYWQEVIGALDNQATIDARRESAKAEQKACETWYKNELKSRGVDEDNILKLKQQIRELETKISRAEQRRSEVLRFDDWYQH-PKLQTQLSDVKRAASEIDQQLKAKTQEVKTRRQQLETERKASDAAQIEASENLTKLRAVMRKNNEEAQGSLGERLRQGEDLLLKRDYLMGSVKQYVEHFDSVIASKSGSGLAETWERAREESSFINDKGIRLLDYRKLV--PQLEQLLNVIVPQSIMALREQGRIFGVDLTAFYDVLADIDRRIASQSARITREVGEDGVSESAVRIRSKISELEFWPELEQFVKAFKNWKADGFNGLPDEEYTNSMRRALDIIGR------AALTGGISKLLEIELRLKEGNSDLIIRQLSHGMAYLILCKFLLAFTRLLRGRAD-IHWPIDE-LGTLHHTNVKKIFDAC----GNNNISVLGAFP................... |
1170 |
| 4 | -34.100 | PF01576.14; O44934_LOLPE/1067-1925; Myosin tail |
ali follow.. |
12 | 7 | ................................................................................................RDLEDAGRKKDMEINGLNSKLEDEQNLVAQLQKKIKELQARIEEL------EEELEAERQARTKVEKQRTELS---RELEELGERLDEAGGATAAQMELNKKREQELLRLRRDLEE-QHESQIATLRKKNQETNELGDQIDQLQKVKSRLEKEKTQLRAEMDDVQSQVEHAGKNRGCS--EKMSKQMEAQLSELNAKIDDQARSVSELTSQKSRLQTEAADLTRQLEEAEHNVGQLTKLKSSLGASLEDAKRSLEDEGRLRAKLQAEVRNLNSDIDGIRESLEEEAESKSDLQRALSRANAEVQQWRSKFESEGAARADELEDAKRKLQAKLSEAEQTADTLHSKCAGLEK--AKSRLQGELEDLAIDVERSSAHANNLEKKQRNFDKVVSEWQHKCNDLQAELENAQKEARSFRVRAQCEEVGDTVASLRRENKNLADEIHDLTDQLGEGGRNTHELEKARKHLALEKEELQAALEEAEGALEQEEAKVMRATLEISQIRQEIDRRLQEKEEEFD---NTRRNHQRAIESMQASLEAEAKGKAEALRIKKKLEGDINELEIALDATNRGKAELEKNVKKYQGQIRELQSQVEEEQAQRDEAKEHYQMAERRCAAINGELEELRTILEQAERARKAAEELADASDRVNELQAQVSTVGSQKRKLEGDVTAMQSD---------------LDELNNELKDADERAKHAMADATRLADELRQEQDHGLSVEKMRKSLESQVKELQVRLDESEAAALKGGKKMIQKLESRVRELEAELDSEQRRHAETQKSMRKVDRRVKELSFQQEEDRKNYERMQELVDKLQNKIKTYKRQVEEAEEI--AAINLAKFRKVQQELEDAEERADQSEGALQKLRAKNRS........................................................................................................................................... |
859 |
| 5 | -30.900 | PF13166.1; Q63PW4_BURPS/9-780; AAA domain |
ali follow.. |
10 | 39 | ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TTLSRIIRSLETGSISPRYASPSFSITISGAVITNNNIPAQGHDIRVYNKDFVDEHLAFLRDEQGHISPFAVLGSKNKEIEVEIDKLEDELGSVENKTGLRHSYQEKKKAHADKKKAAQDAQDELDKKIFDKANKNPTGIKDANYDVRKLKLDIKTVQDKKIAPLDDADRSSKVKLLSEVALPDIEKRLSFNSSLPALAKSTVELITKKIKPSAPIQELLNDAILQNWVKSGIPLHEATR---PADLWKRLGDHFNQESQDLEKDLDSVLTKISNEKTRIKNVVTVDRKNFYSANQATFDNLKADLDDAINNHEKSLQSLEDELNARKKDIFTERSTIDVQDNTVSISQKVSLVNELIERNNKTTTSLEEDQKIARNELSQFTIDIDLAGEEKKIKALEDQITKAKDELDAVEAEGKKRVDRVKELRTQLRDRGAEQVNQYLGHFLGHGGLSLSAVEEANTATYRFQILRGDQ-AAYNLSEGECSLVAFCYFLAKLEDIETKGKKLIIYIDDPISSLDSNHIFFVFSLIENYYRYEQLFISTHNLEFLKYLKRLTKP....... |
635 |
| 6 | -29.200 | PF10174.4; Q7Q0K7_ANOGA/59-838; RIM-binding protein of the cytomatrix active zone |
ali follow.. |
10 | 1 | ..............................................................................................................................LKAKLENAQGEQESL------KQEMERGQAGIQRIVSERDKAY---AELEKIREELERTQATLGKSQLTQEKLQNSLDKAQ------------NEIDHLQEKLDKSGGETRRLQLEKEKINYEFENIQSQLDKSLGQASRIQKEKEAAQ------------MDLDRYRDKADKLQSSLARLQKERDVLSDELEKLKEKSESTQSTALKYQRERDAIQTELEVVKERWEKAHQVHQKLQMERDDATTEIDILKEKLDKALYASQKLIDEKD-----TSTKEFEKMLEKYDRAQNEIYRLQSRVDTAEADRNRLE---------VEAERSALAAAKAREDLRKIQEETTRLQEACDRAAMQLGRSKE----------------LEDKAKEDVDMIRERLDKCQTDLRRAQSEKDNQQAEIERLTYELDRSHNLYTKQTASLDSAQEEIARYGLEIEKMRERYEKTAAEL------------RRLQENESFSREARRMKDENDRLREKYDKVIVELENFRGKSQYEQETFDKMKEKFETRENEFQTMELKLHETSLQLDLARAEVTKLISNQDKQRADAERAHIEYEKIRDKHEKLIKEVERLRQNPQSAIALAATSTVSLADKNELDRLRDRLEKALQSRDATEME---------------AGRLAKELEKAQLHLTKQQEVYEATRIEFERMSAELTRVLERLEKSEA---------EKETLRQSTKIYEKHHQQHASNHHIEQSLMKLEADNKQLMAERDQLVMQLEKSQDMLMSFQQELNAAEVELQRQCEENRRLKSSPQQPGSTKLKQMLQETGARGDNELEQWRKVVEQEKNRADQAEKAAIELQKRMQ..................................................................................................................................... |
779 |
| 7 | -26.900 | PF05483.7; SYCP1_RAT/28-813; Synaptonemal complex protein 1 (SCP-1) |
ali follow.. |
10 | 60 | ............................................................................................................................HYQEGVNDSDFENSEPM------SRLYSKLYKEAEKIKKWKVSIE---SELKQKENKLQENRKIIEAQRKAIQELQFENEKVS------------LKLEEEIQENKDLIKENNATRHWCNLLKETCARSAEKTSKYEYEREETRQVYVDLN------------NNIEKMILAFEELRVQAENARLEMHFKLKEDHEKIQHLEEEYQKEVNNKE------NQVSLLLIQSTEKENKMKDLTFLLEESRDKANQLEEKTKLQDENLK------------ELNEKKDHLTSELEDIKMSMQRSMSTQKTLE----------------EDLQIATKTIYQLTEEKEAQMEELNKAKTTHSLVVTELKATTCTLEELLRTEQQRLENNEDQL---------KLITMELQKKSSELEEMTKFKNNKEVELEELKTILAEDQKLLDEKKQVEKLAEELQGKEQELTFLLQTREK-----------EIHDLEVQVTVTKTSEEHYLKQVEEMKTELEKEKLKNIELTANSDMLLLENKKLVQEASDMVLELKKHQEDIINCKKQEERMLKQIETLEEKEMNLRDELESVRKEFIQQGDEVKCKLDKSEENARSIE--YEVLKKEKQMKILENKCNNLKKQIENKSKNIEELHQENK-ALKKKSSAENKQLNAYEIKVNKLELELASTKQKFEEMINNYQKEIEIKKISEEKLLGEVEKAKATVDEAVKLQKEIDLRCQHKIAEMVALMEKHKHQYDKIVEERD----------SELGLYKNREQEQSSAKVALETELSNIRNELVSLKKQLEVEKEE--KEKLKMEQENTAILTDK................................................................................................................................................................ |
785 |
| 8 | -26.900 | PF05911.6; Q10P54_ORYSJ/79-939; Plant protein of unknown function (DUF869 topsan) |
ali follow.. |
11 | 1 | ..................................................................................................................................................KDALVKQHAKVAEEAVSGWEKAE---AEASALKLQLETVTLAKLAAEERAAHLDGALKECMKQVRTVKEEGEQKLHDVVFAKTKQWEKIKAEFEAKLLEFEQELIRAGAENDALSRSLEERGDLLMKI--DEEKARAEAEIEVLKNTIQSGEREINSLKYEIHVVSKELEIRNEEKNMSVRSADVATKQHMEDVKKISKLEAECQRLRGLVRKKLPGPAALAQMKMEVESLGRDYGESRLRRSPAKNSSFHRPMSPMSPVPDYAFENLQHMQKENEFLTARLLSMEDETKMLKEALAKRNS--ELQTSRNMYAKTAGKLRGLEVQMLTGSQRKSTSNPNMDIHFDGALSQNGSNPPSMTSMSEDGVDDEGSCTESWANALVSELSHIKKEKGAKSSVTEGEMEKLACLSSEANGHVSTVEKMKIDDTEASLSGITERDGVKDSQSVLALPGTPSNKLQLS-LLKLQSRISSLLDSESPQNNAGNILDSIRNILKDIEDEADSSNDSKTHHGDMVEVADNGSLMKHSSSGSKHAMDQELVNAILKIQDFVKSLDQEVSKFQGQSSDCDGLCDKIQQFSALVEKALSNENVLNDIVMTLSLILSGTSEIKVQLEPLKDSISGPCLPRSSSDPEIEGPTDSGCDVKTAVQICSSEEFEQLKSEKLNLEAELSKCNEVIEETKFRFKELEKSLE---------------ELTSKLVASEKSNSLAETQLKCMAESYKSLESRKAELENEIKVLQSKIEVLTAELDDERQNHQEDITRYRDLEEKIERYENEKEIAAAAEKLAECQETILILGRQLQSMRPPAESMGSS.............................................................................................................................................. |
861 |
| 9 | -23.900 | PF09730.4; Q3TBD4_MOUSE/9-723; Microtubule-associated protein Bicaudal-D |
ali follow.. |
8 | 2 | ........................................................................................................................................................................QAHTNHKKVAADGESREESLIQESASKEQYYVRKVLELQ---------TELKQLRNVLTNTQ----------SENERLTSVAQELKEINQNVEIQRGRLRDDIKEYKFREA--RLLQDYSELEEENISLQKQVSVLRQNQVEFEGLKHEIKRLEEETEYLNSQLEDAIRLKEISERQLEEALETLKTEREQKNNLRKELSHYMSINDSFYTSHLQVSLDGLKFSDDTVTAEPNNDAEALVNGFEHSGLVKSSLDNKTSTPRKDGLAPPSPSLVSDLLSELSEIQKLKQQLVQMEREKVGLLATLQDTQKQLEQARGTLSEQHEKVNRLTEN--------------SALRRLQAGKERQTSLDNEKDRDSHEDGDYYEVDINGPEILACKYHVAVAEAGELREQLKALRSTHEAREAQHAEEKGRYEAEGQALTEKISLLEKASHQDRELLAHLEKELKKVSDVAGETQGSLNVAQDELVTFSEELANLYHHVCMCNNETRVMLDYYREGQGKAGRTSPEGRGRRSPVLLPKGLLATEVGRADGGTGD---------------NSPSPSSSLPSPLSDPRREPMNIYNLIAIIRDQIKHLQAAV-----DRTNELSRQRIASQELGPAVDKDKEALMEEILKLKSLLSTKREQITTLRTVLKANKQTAEVALANLKSKYENEKAMVTETMMKLRNELKALKEDAATFSSLRAMFATRCDEYITQLDEMQRQLAAAEDEKKTLNSLLRMAIQQKLALTQRLELLE..................................................................................................................................................................................... |
714 |
| 10 | -23.000 | PF07111.7; CCHCR_PANPA/27-782; Alpha helical coiled-coil rod protein (HCR) |
ali follow.. |
14 | 62 | ................................................................................................................................................SQQAEVIARQLQELRRLEEEVRLLRETSLQLEAQAMELEALARAEKAGRAEAEGLRAALAGAEVVRKNLEEGSQRELEEVQRLHQEQLSSLTQAHEEALSSLTSKAEGLEKSLSSLETRRAGEAKELAEAQREAELLR--KQLSKTQEDLEAQVTLVENLRKYVGEQVPSEVHSQTWELE--------------RQKLLETMQHLQEDRDSLQATVELLQVRVQSLTHILALQEEELTRKVQPSDSLEPEFTRKCQSLLNRWREKVFALMVQLKAQELEHSDSVKQLK----------------GQVASLQEKVTSQSQEQAILQRSLQDKAAEVEVERMGAKGLQ-------------------------------------LELSRAQEARRRWQQQTASAEEQLRLVVNAVSSSQIWLETTMAKVEEAAAQLPSLNNRLSYAVRKVHTIRGLIARK-LALAQLRQESCPLPPPVADVSLELQQLREERNRLDAELQLSARLIQQEVGRAREQGEAERQQ---LSKVAQQLERELQQTQESLASLGLQLEVARQGQQESTEEAASLRQELTQQQELYGQALQ--------EKVAEVETRLREQLSDTERRLNEARREHAKAVVSLRQIQRRAAQEKERSQELRRLQEEARKEEGQRLARRLQELERDKNLMLATLQQEGLLSRYKQQRLLTVLPSLLDKKKSVVSSPRPPECSASAPIAAAVPTRES---------------KGSLSVLLDDLQGLSEAISKEEAVCQGDNLDRCSSSNPQMS....................................................................................................................................................................................... |
755 |
| 11 | -22.700 | PF05557.8; Q9W6G9_XENLA/2-716; Mitotic checkpoint protein |
ali follow.. |
10 | 2 | ..................................................................................................................................................DSEDNTTVISTLRSFNKFLSQPL---EGTAPSLGTSTSTGASLQMQFQQRFLLEDQAAQIRSKSNLIQVEREKMQMELSHKRARELEKAASTNAKNYEREADRNQGLHTRIKALEEKENEFQNKLQEQ--NEMIKSYKKTIEAQSKKLLEKEDKLSESNENISVLKGKASELQWKIMNQEMQIKTQETEKQELTEQLEIHRKKLQESNEKMQALHELQAQNADNEQKIKSLEQKLSAQEQDAAIVKSMKSDLTKPKLERELQQLRDENAYHREMKENNALLKEEVEGLRRAAERFNKMKEDLVGSEIEKEQLVKKLKLWENLEQSTGLNIRTPDDFSRQIMAV-----------------------QQRELKLKEENMTIQISARMLETSRQQLQEELLKVQSGFLEEKKRREHQEALVRRLQKRVLLLTKERDGMRAILDS-------------------YDSELTPTEHSPQLSRRLKEAEDILQKVQDHNAEMETQLSEALEDAGIQKQKSELLTAELKVLKSQMGSSDQNISFTNEAMSALRLKIEELEAERGRLEEENKILEMRLESLNLQGCYDPSRTKVIHSLNPASKAKQQRTDTVRHLQEECDKLREIVRILEGGAQ-----------IPDKLEATGSPQSSQELAELKKQVESAELKNQRLREVFQTKIHEFRTACYML..................................................................................................................................................................................................................................................................................... |
635 |
| 12 | -21.900 | PF05622.7; HOOK3_HUMAN/5-718; HOOK protein |
ali follow.. |
11 | 113 | ...............................................................................................................RMLQLILGCAVNCEQKQEYIQAIMMMEESV------QHVVMTAIQELMSKESPVSAGN---DAYVDLDRQLKKTTEELNEALSAKEEIAQRCHELDMQVAALQ--EEKSSLLAENQVLMERLNQSDSIEDPNSPAGRRHLQLQTQLEQLQEETFRLEAAKDDY--RIRCEELEKEISELRQQNDELTTLADEAQSLKDEIDVLRHSSDKVSK------EGQVESYKKKLEDLGDLRRQVKLLEEKNTMYMQNTVSLEEELRKANAARSQLETYKRQVV------------ELQNRLSEESKKADKLDFEYKRLKEKVDSLQ----------------KEKDRLRTERDSLKETIEELRCVQAQEGQLTTQGLMPLGSQESSDSLAAEIVTPEIREKLIRLQHENKMLKLNQEGSDNEKIALLQSLLDDANLRKNELETENRLVNQRLLEVQSQVEELQKSLQDQGSKAEDSVLLKKKL-----------EEHLEKLHEANNELQKKRAIIEDLEPRFNNSSLKIEELQEALRKKEEEMKQMEERYKKYLEKAKSVIRTLDPKQNQAAPEIQALKNQLQERDRLFHSLEKEYEKTKSQREMEEKYIVSAWYNMGMTLHKKAAEDRLASTGSGQSFLARQRQATSSRRSYPGHVQPATAR....................................................................................................................................................................................................................................................................................................................................................... |
714 |
| 13 | -16.900 | PF13175.1; A9A6W0_METM6/4-391; AAA ATPase domain |
ali follow.. |
12 | 227 | ...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KTYKDSKIPNIIPFANLETDEFIKDLQKVNLDINLIKSTDRQRKKNHHGAININLQEDYSKYWTQSESNLEITWDNNNVEFWVKE-DNTSYTPEQRSKGKQWHLAFYIRITARS---KEGKNNILLIDEPGLFLHAQAQEDIINKLEDASKTMSIIYTTHSPYLL................ |
388 |
| 14 | -16.200 | PF04094.9; Q8S5S8_ORYSJ/246-1073; Protein of unknown function (DUF390 topsan) |
ali follow.. |
11 | 371 | .......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PLLQALAATNTTVLDGLSAQMEVLQAERAELDAAWARVEEGRRSVEAMVEAGRKAHRRHTSELEARRRDLAEIAREVEEERETALIATTVLNEARDDLRLQYGSRAAELEKKLDAARGVLDAAAARERRAAENEAASRQREEALEARATALEERARAKERDMADRE----------------AAVAIREATLAAHEAACAEEESALRLREDTLTERGRALEEAEAAAQRLADSLFLREAAREEQARRNLEGARAKRAALDQRVAELEARAKELDARAHSGGAAVGDGDLAARLAAAEHSIAELQGADSSAGEVEALRLAGEVGPGMLRDAVSRLDRAGRQAGLWGGRCAKYAANQGGLAQRLSEMAGTLQRLPEELEETIKSSSRDLARGAVELVLASYQARDPDFSPWAALEEFPPGTEDGARAQVRDAANHIVHSF---------------------------------------DGTAPR--LAFALDSDEEGGDDGA------GDG----DEAG........................................... |
823 |
| 15 | -16.000 | PF05701.6; Q9FWW5_ARATH/24-519; Plant protein of unknown function (DUF827 topsan) |
ali follow.. |
11 | 1 | ...................................................................................................................................................RAPFQSVKAAVSLFGEVAVSKQRSTPR-RLSSESVCDKETQLMLVHKEFMKIKQKLDNAE------------STRSRALDDLSKAKKTMEDLSNKLETVNKSKQSAIDTKETVQQREEQLEHDKC---------------HGSPPHHHELDVAREQYISTTVELDAAKQQLNKIRQSFDSAMDFKATALNQAAEAQRALQVNSAKVNELSKEISDMKDAIHQLKLAAAQNLQEHANI---------------VKEKDDLRECYRTAVEEAEKKLLVLRKEYEPELSRTLEAKLLETTSEIEVLREEMKKAHESEMNTVKIITNELNEATMRLQEAADDECSLRSLVNSL-RMELEDLRREREELQQKEAERLEIEETKKLEALKQESLKLEQMKTEAIEARNEAANMNRKIESLKKETEAAMIAAEEAEKRLELVIREVEEAKSAEEKVREEMKMISQKQESKKQDEESSGSKIKITIQEFESLKRGAGETEAAIEKKLATIAAELEEINKRRAEADNKLEANLKAIEEMKQATELAQ........................................................................................................................................................................................................................................................................................................................................................................................................................................... |
496 |
| 16 | -15.900 | PF13779.1; A9D7X3_9RHIZ/37-855; Domain of unknown function (DUF4175 topsan) |
ali follow.. |
11 | 391 | ...............................................................................................................................NPLAAAVVEQRGVLALDAQNLPRVFDLHDALTIAPEETIPDLSHYLLLQSVRGRLENARSD-EDLHAAIDYMWGVALQLED-GNLSLAERRLRDAQNALAEALENGATDEEIAQLMDELREAMQEFLQELARQNQNNPASEMQQAMPENMLRQRDLDNMLDQIENLARSRDQAQQMLQELQRMMNNLQAGRQQRQQQQGGPMRQQMDKLGELMRQQQQLMDETMRADRDRQSQSGEGRDRQEQGQNQPGQGQDQGQQGQGSQSLEEMLGALGR-SQQELQDALGQLQRDLEGMGINPSEGFGEAGEAMGDAAGNLQQGQTGQALGDQGRALQALRQGAEDMMNQMMQAMGNQQGDAEGEGPDQNGNRSADDRDPLGRPRATTGPDFGSRVQVPDE--IDIQRAREILDAIRKRLGDQLSPEVEKRYLERLLD......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
819 |
| 17 | -14.800 | PF03999.7; PRC1_HUMAN/37-615; Microtubule associated protein (MAP65/ASE1 family) |
ali follow.. |
7 | 1 | ..........................................................................................................LQRTEVVKKHIKEL------LDMMIAEEESLKERL------IKSISVCQKELNTLCSELHVEPFQEEGETTILQLEKDLRTQVELMRKQKKERKQELKLLQ---------EQDQELCEILCM-YDIDSASVPSLEELNQFRQHVTTLRETKASRREEFVSIKRQIILCMEALDHTPDTSF-ENIATLQKLLRQLEMQKSQNEAVCEGLRTQIRELWDRLQIPEEEREA---SKAKVRKALQLEVDRLEELKM--QNMKKVIEAIRVELVQYWDQCFYSQEQRQAFAPFCAEDYTESLLQLHDAEIVRLKNYYEVHKELFEGVQKWEETWRLFLEFERKASDPNRFTNRGGNLLKEEKQRAKLQKMLPKLEEELKARIELWEQEHSKAFMVNGQKFMEYVAEQWEMHRLEKERAKQE.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
413 |
| 18 | -14.800 | PF06160.7; EZRA_BACP2/3-562; Septation ring formation regulator, EzrA |
ali follow.. |
12 | 103 | ...........................................................................................................................LTHIEDLLSAADSNIEDI------LKEIADLVTSEEQNRKDIEKVKEQYQTVKNLLAYSHLYGTLYDKMEQDLDEAWEGIKQYEEETENGNYMKARKILLEQDRRLDQLQLYINDVPKLIADCKQTVPGQLTKLKDGYQEMSEKGYKLEHIQITKELETLNKNLEEASSILQMIDDAIETLYDQLEAEVEAGQEIKSRMPELTEAFEKLEQDHTQTKAETALVKESYKLTAGELDQQKAFEKRLEEIEKLMKQIREKLDRDHVAYSLLMDEINQLETEDAKALHDTFKGHLQSLRKEELQARETLAELKTMLTDTVRQLHKSNIPGVPAEMKERAEKAQEMIHQVHEQLENLPLNMPAVNQQLKEASDTVRNVVDETEEMLSKVDQIERIIQYGNRFRSQNHILSEQLKEAERRFYAYDYNGSFDIAAAAVEKASPGAVQKLLAQQEK............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
560 |
| 19 | -14.800 | PF07888.6; Q7ZTT2_DANRE/1-545; Calcium binding and coiled-coil domain (CALCOCO1) like |
ali follow.. |
10 | 63 | ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EGYQKGADANCSVAFHPSYLPIPGVEEYQFVYVDGRGDVCAISSQFTFAAPRPLDELVTLEKSGEGEEDGDDLLLVVPKALILQNLLEGCQRELHELHKKFEAVNGDVENERQRWKTDRDEFEILRSDMRSQIEQLKTNLRHSTEKTEELERKHKEAQSSSESMSAEFNALLAERAENQQRIKELEDSATLTQQKQDIEAELERMKERVKKMTIQRRDEETERI-DLQLENEQMHADLRTLQERLEASERSTGALRRDLSELGSLQSHSHAELHQVRLQSAQMSLQLSQANL-----------ALREGQSTWAQERETLRQSAELDKDRVQKLSRELQKKEEWLQEERSEREKLEVELGIEKDCNRELRASLRALQKEQEQHQL--EKQELLDHIHVLELRLDTETDAKWAEAAATPICQFAKSYLHRA....................................................................................................................................... |
478 |
| 20 | -14.600 | PF05667.6; CCD22_AEDAE/1-554; Protein of unknown function (DUF812 topsan) |
ali follow.. |
10 | 277 | ................................................................................................NNITVETKPGKTPLESLQEEIDALQQEIVQHSEEGVQLESSRKET------DESIEEYRKTIVRLKEEKKIKERTHILLEDPEVNVKKLEAIIAAGGERMKKLQDQWDAHRIPLV--------DTLEAYRLKNSDKLSKSQQVLDQIESTRQKCEEVVIDLQTKGAMYARLQKEFEKL---NKTVSRTAYTSRILEIIGNIRKQKNGIDQILQDTRSLQKEINNITGQLDRRNAKKDEHSKRAYKLLVTLHSDCEELIKLVQETGAIKREVRDLEDQIENEKGR............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
553 |
| 21 | -14.500 | PF09787.4; A7USX6_ANOGA/12-516; Golgin subfamily A member 5 |
ali follow.. |
7 | 95 | .............................................................................................................................SKPEPSYSIEQELAAI------KIVLAEIKAERDELKSELDSTLSQQLSNGETESKLLDLEVLCQNLSEEKMALAGKLLSLEEANGKYV-----KSISELESTIAKHIQSEQELNSKLDMARLETENALTELQQYRVRAHATLQLKEKTRTDSTDSTDSKHSNAEQILQIELEQTRQEKANLAEELTSLNDRMKQREAQWMNAEEKLRVTVHALEQNVQRLQ---QQILLDADKFSVLEDDFKLKQRELASVREDLIKQRTSFTLRLHEKESENSKLRNKIHTRPVSPLNDQEDRLASLTQSLVQKQ----------------TALETVTVERNALRIQLEKLENQYRNTASQVRQQRAV................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
436 |
| 22 | -14.000 | PF08580.5; Q6FY01_CANGA/41-592; Yeast cortical protein KAR9 |
ali follow.. |
10 | 1 | .........................................................................................................................SSIEDLCDVLEWITTQMNRI----------------LEIFPQIIDSTGIEVSSLLEYLDWLQERKELLFELVNDINSIGPFLSDILEGIEANLNTDPNKSLDEHEMHL----------IDLIERCSTLRDDLDPWLNKLRKLLDATLEFKEIS--NDHMDGLDKVVSENIQSCFDIQEERFTSPVRHAPSFTLEQIVDLLKQN--------------SDSNAISVPTFNKQEKLISERFLELRRSVPAIEKSLTDILPN------------------------RIDNFARRDMTNIDSLAEFLRDKYKVLMKKYEFMSSEISELNAELIDKRWNILFVNLNHEINFILDDYEKLKKKLNSVEEIGINVQIREKMSHQ----------------------TQKSLTIERTFKVIFKAQEFSLLDAGIASKTNEMKNRWEKVRVDDKLLRSVSVDSGPEISSVTKDFES............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
380 |
| 23 | -13.700 | PF03429.8; Q9RQF5_ANAMA/1-720; Major surface protein 1B |
ali follow.. |
9 | 3 | .................................................................................................................................................................EDDKQQQQNQSDVVQAISAVFQRKSAELQRLNDFIKGADGTLKNVH---------PHMKSLEALSKQLSE------KIAAEAAAKADAKYESVGLRAKAAAALGSLGRLFRSGSKGGYTPQDIDALPFMDEAPDTGEKIEVPAGEEQEFGKAAAWGLAGFKRTVDESLEMLDRGMHMLAEGQAQISQGIADKST-----ALVREGLETSRLGAGLCRNGLVEASYGVSYANKTMGKYAGKGLEKCKNKLDDACHKWHDALNEIESLRTAIDAKAEQQVEGEAWSPEGVSANTFYRGLHKIGAAIAVAAQATWEGLAMTGKFMGAVAKLAGAVSMCVAAYTAAIAGVILPA---------GIPLAFMGPESKLAEYVDRAASYLHSNVEQATKDLMASEFAMMTFGGIMTCAKLMKGSFAAVNQKFEEINATL------------------------AREGTDIAQGIKETYKSIGDAFKSVNTGIAKWTTDKWTAALAGYASVEQLEE-AKEADRAQAEQRAEAQAMTERVA-------------------------------------------QERAATVAAGTETIKTIVSDMCNELAQICGLSQAERDALVQSFIP---------QPPRTTKEIVSQMCNSVKSAFGSISHITNVIRQAGKDAQKIDP---------QVKVAEISPETIYAMSEALYALNMQESAAINNALLEAVNDSSKDDQAIVTDLINATIEVCTEQTNTLAGHTAEVQAGLEAAGIKLDDAHTTPEAKELAQAAEGLATAVNEASAKIQSLNQQESQIAQGGQHAAQQQSSGWSR................................................................................................................................ |
720 |
| 24 | -13.300 | PF10168.4; Q707M9_XENLA/4-726; Nuclear pore component |
ali follow.. |
9 | 462 | ...................................................................................................................MICITCDFECIARPLLTTIRPPSPPLLCSQIDKSSTEILPHVLADVKGPFIHIRGILRRNSANPLLLNSSSKDSSPPPEECLQLLSRATQVFREEYLLKQDLAKEEIQRRVKLLIA---QKEKQLEDVRYCREERKSLTETAEHLAEKFEEAKERQEDLIN-----RLKRILRSFHTQLPVLSESERDMKKELQATTEQLQHLGNCINQVKRKMSYQEKQMEKGKSPRKSLTLSDYQKKNIKTVLKEHGEHIQEMVKQINNIRNHVN.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
722 |
| 25 | -13.200 | PF07902.6; Q1CPP5_STRPB/1-621; gp58-like protein |
ali follow.. |
9 | 2 | ..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SRDPTLLIDESNLTIGSDGRAYYTFKADGDTKSVKLANNKCIGTTRFNQLMIERGGKPTNYVAPVVVEGSGESTGLFKNLEGALSQLKELNLELTDTVNSQLWAKIKLTTNGMLREYHRDNITEIVESANGIATRISEDTDKKLALINETVSGIRRDYQDADR--QLSSTYQAGINGLKATMANDKNDLKAVIQATAQGLSQ----------------KYDDEIQQLSA-TTSSGTTEAYESKLADLRAE---FTRSHQGMRTVLESRISGLQSTQQSTAYQISQEIKNREGAVSRVQQDLASYQRRLQDTEKNYSSLTQTVRGLQSTV------------------SAPNRGLESRVTQLAGLIEQKVTRGEMESYIRGAGDSIMLAIKGKLPQSKMSASEIVSAINLNGYGVRISGERIA........................................................................................................................................................................................ |
387 |
| 26 | -12.800 | PF10212.4; KRLAQ_CHICK/256-770; Predicted coiled-coil domain-containing protein |
ali follow.. |
10 | 1 | .........................................................................................................LAGQALSFVQEIVTALLNF--------TYTEQKAQIFPIDSATDTISPLNQKFSQLHENAFYVRPLEEGMLQLFESITEDTVTVLETAVKLKAFSEHLASYLCFLRKI-----LPYQLKSLEEECESSLCTAALKARNMELHRDMKRLTAIFEKLHTYVSLLALPSTKPEGLLR--NYSLVFTNIAASLHGSHDILKDISKHYSQKATLEQDVPTATQKLVTTNDCILSSILSLTNGVGKIASFFSNNLDHFTSSLSYGPKGGTEFISPLSAECMLQYKKKAVAYMKSLKKPCADSVPYEEALANRRVLLSSTESREGLAQQVQQSLEKIAKLE---------QEKEHWMLEAQLAKIKLEKENQKLKNSLSGHLAETVQERSVLSNTAEQKEETTEKSQREPIKTTSLIGMLTITTDNEKVPDVESREDLIKKHYMARIAELSHLQLADSKSVHFHAECRALAKRLSLAEKSKESLTEELKLASQSISRLQDELMTTKRSYEDQLSMMSDHLCSMNETLTKQREEIDTLKMTSK........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
515 |
| 27 | -11.900 | PF09728.4; Q5RIN4_DANRE/94-406; Myosin-like coiled-coil protein |
ali follow.. |
11 | 1 | ...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KGLGKEAASLLQSLNKLGSPEEKVEMVLKKYSELVDEHRTEKKQLEQFQQRQGLLVKQRDQLQEHSRAILARSKLETLCRELQRHNRTLKEESLQRLREDEMKRKEITTHFQSTLVDIQSQIEQHSNRNNKLCKENSELAGKLKTIIEQYERREESLEKIFKHRDLQQKLSDAKLEEANMLLTQAEEKHKREKEYLLKEAIDKTKKYCTLREQELQMKKQLVLYSQKFDDFQNTLAKSNEIYVTFKQEMDKMTKKMKKLEKETRFESCNKALVEMIDERSEKGKEFELFTLKIDRLETLCRALQDE....................................................................................................................................... |
312 |
| 28 | -11.700 | PF13476.1; C4P4D4_ARATH/25-232; AAA domain |
ali follow.. |
12 | 24 | ITGQNGSGKSAILTALCVAF--------------------------GCRARGTQRAATLKDFIKTGCSYALVYVELKN--DAFKPEIYGDTLIIERR--DHQGRKISSRKEELRELVEHYNIDVENPCVI---MSQDKSREFLHSGNDKDKFKFFYKATLLQQVDDILQSIGTKLNSANALLDEMEKTIKPIEKEINELLEKIK............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
208 |
| 29 | -11.300 | PF04582.7; Q9DPB5_9REOV/1-326; Reovirus sigma C capsid protein |
ali follow.. |
12 | 10 | .......................................................................................................REVVSLILSLTSSTTTNPGDLTAVYERLTNLEASTKSL------RQSLSSIVSDLSDVSVDLQDTT---RALDDAIATLKGLNTTVAALQNSVASLSSTVNGLT------------DISSAHSEALSFLRTTIDGNTVAISNLKGDVSTNGLNIADLQNRMKSLESSTSHGLSFSPPLSVADG-LDMDPYFCSQRSAEAKLMQFQWMAKGTSGSSDVIDMTVNAHCHGRRTDYMMSSTGGLTVTSNAVSLTFSLDYITNMPSDLSRL...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
263 |
| 30 | -11.200 | PF06818.10; Q4RYH9_TETNG/478-682; Fez1 |
ali follow.. |
8 | 1 | ..................................................................................................................................................SKWEVCQKSGEISLLKQQLKEVQ---GELAQRVGEIVSLRGQLRETRGELTNTQVLLQEAH------------GTTRTRTLELEVCENELQRRKSEAELLREKAGRLEAELAHLKDALASQGPGNRQCQVFPEDQEQLLARAQEPSGGEVLQNMSVKMDRMRAELSYEHQRAEQQMSSFE--------------EERRIWQEEKDKVIRYQKQLQQNYVQMYRRNRELEQLLQE............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
205 |
| 31 | -11.100 | PF09789.4; Q16UI1_AEDAE/24-343; Uncharacterized coiled-coil protein (DUF2353 topsan) |
ali follow.. |
10 | 1 | ...................................................................................................................................................HRKLQSKVEALKIMRNELEKYR---SERDQFKLMAETLQMRYSAMKSSLNSPEFQAAGFGHSSAVSLLVNQTRERNISLSEVEALRQRVHELEGDIDVLRTKNFDLQAAFNKMKSTEETKLRDRKGIVWDEEKSKLIAQMETLKKKNAQLQYDVRSLLDEKEDVVMERDAYKCKAHRLNHELSVMLKGDQSQQKI-VDVDGLILENKYQQEKITNLENELELSRQSATKYKNMLDTKRKKGIIKLGTNNNQRVMSHSQVKDLLERGTVEELPLKAATISELKS-------------------LCLALLDNVNDKSLALSHQKKTNKLLAAKITELEQRILAL............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
320 |
| 32 | -10.900 | PF13558.1; A3YC50_9GAMM/971-1061; Putative exonuclease SbcCD, C subunit |
ali follow.. |
18 | 31 | ................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GTGSGGEKQSFYVAIASSLATAWGTLSNPGRALLDEAFDKLDEENLKNAMDFMGD................................. |
90 |
| 33 | -10.800 | PF09726.4; Q4SIM5_TETNG/2-648; Transmembrane protein |
ali follow.. |
8 | 157 | ........................................................................................................................................................................................................................................................................................................................................................................................................................................................................SYKMRLRKQKEVQKENEFYMQLLQQALPPEQQMLQRPEKETEEVTKGISEVEPSVTSQNGAPPGKKSSTLQLPELEYREKAKDSTGKEGKKVGINNNSIIHLDSKLQEAEYIENYAGAKRLNNDLAGENTDSNTHS------TSKEEMAGTGKNFKYNSGGGANISNSSPRNHSSSNGSVLSGSTSKNEKKQKGAGKAQKDPVENCIPNNQLGKPDALVRLEQDVKRLKTDLQANRQLESELRSQLSSLSSQDRSLRSELGPVRQDNELLQNKLHSAQAKQKDKQTISQLEKRLKAEQEARTLAEKQLAEERKRKKMEEATAARAVALAAATRVESTDSLRSRIRDLETECKKLTMDMKLKEEQIRDLEGKCQELRKYKENEKDTEVLM---------SALSAMQEKTQHLENSLSAETRIKLDLFSALGDAKRQLEIAQGQIHQREQEIAELKQKIAEVMAVMPSLSYSSDGSNLSPV--TPHYSSKFMDNSPSSLDPNASVYQ....................................................................................................................................................... |
645 |
| 34 | -10.800 | PF04108.7; ATG17_PICAN/6-396; Autophagy protein Apg17 |
ali follow.. |
12 | 2 | .......................................................................................................QWVADARANLAHAEQVCNDANMYLTSTSEKLRRREMKVPKLIYYLDALKQQLRLLEIIRDSLVLNLNGVME--KRAALQSQLLKDVDRLHQTIDTLKNTVVVFDGQTTLYEYISE-SGVEELFNGVSQNLKDIQTLIKG-NRTDALLIRLTSDLDHLSNELNALDSKFRDMRLVDTQSSSIDPISKLLEINAELEHDMVAILTSFNNHYDQCEKGEAILKDPAVPQDEKDELVSVLQNDVEELPEAQRSLTSNAEIIKKNCKEVMKILDIFEDYFQRVETYVCELQEYGESKLRVQLKEFSDINTEVSRKLEIAQTHQDELVQYNSDFQQFVRSYYSL------ILELDRRMRVNEHISSAIDNFRSTISNIVEKDHEKRME................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
373 |
| 35 | -10.700 | PF04163.7; KAR5_SCHPO/1-544; Tht1-like nuclear fusion protein |
ali follow.. |
6 | 155 | ......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ELSIEVNMNVTLVQKQLEMVILHLRNFESVTDKMNQRIDKFDGKFNSVIENSFKDINFRVNQEIMGLVELQNHQQEGMVQQKEILSTIKQLKSEIFDINSFFANFIEESAGYSN----SLIEKLNEKFTSENAIALSAIGKYTSEFSAFMEKRIKNLITTTEDSLQQSVQSNIDFVNSGFQPLYDLTIQLKEELQSLKRLSSEQQNLQH-EQILQWKSDFLNVSKDHLKVLQQLRPLIDIVEKFMNVYFKGLS..................................................................................................................................... |
403 |
| 36 | -10.700 | PF03915.8; A5DRI1_PICGU/262-666; Actin interacting protein 3 |
ali follow.. |
10 | 75 | ............................................................................................................................SESDSSNQELLKAINAL---RQVQELQYADLAAQIGNLALQPKKVNETTKEGTTQPTNVLGIEEITSLKQQFTSLRSMQAQYKRDVE-----ADISSVIAKVKAFQEGGLNVSKSSNR-AYMEGCHSKLSEESDILLTKVDDLQDLMEAMRKDVAQRGVRIGEKQLKNTNREIQAAKNSLKEMSQYITRERVVWKRIWES-----------------ELDKVCEEQQFFNLQGDLTVDLEHDLKKIEKTFDLIEQCSLEQSKQNAQRRNKFFVPLMEPGKSLDKMKDAILTSVVALNPDHDRRLDAITRAEKLRDRERELMRKDQFQEELEDFVGDKKFKNAVGIDEVERLRRERDS....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
405 |
| 37 | -10.600 | PF01044.14; CTNA2_CHICK/18-867; Vinculin family |
ali follow.. |
9 | 1 | .....................................................................EIRTLTVERLLEPLVTQVTTLVNTSNKQNFLEKGDQIAKESQDLKEELVAAVEDVRKQGETMGTMVRAARALLSAVTRMADVMRLLSHLKIVEEALEAVK-NATNEQDLANRFKEFGKEMVKLNYVAARRQQELKDPHCRDEMAAARGALKKNATMLYTASQAFLRHPDVAATRANRDYVFKQVQEAIAGISNAAQATSPT-DENKGHTGIGELAAALNEFDNKIILDPMTFSEARFRPSLEERLESIISGAALMADSSCTRDDRRKRIVAECKRAVRQALQDLLSEYMNNTGRKEKGDPLNIAIDKMTKKTRDLRRQLRKAVMDHISDSFLETNVPLLVLIEAAKEVKEYAQVFREHANKLVEVANLACSISNNEEGVKLVRMAATQIDSLCPQVKVAQDNMDVFKDQWEKQVRVLTEA---------DDITSVDDFLSVSENHILEDVNKCVIALQEGDVDTLDRTAGAIRGRAARVIHIINAEMENYETGVYTEKVLEATKLLSETVMPRFAEQVEVAIEALSANVPQPFEENEFIDASRLVYDGVRDIRKAVLMIRTPEELEDDSDFEQEDYDVRSRTSVQTEDDQLIAGQSARAIMAQLPQEEKAKIAEQVEIFHQEKSKLDAEVAKWDDSGNDIIVLAKQMCMIMMEMTDFTRGKGPLKNTSDVINAAKKIAEAGSRMDKLARAVADQCPD--SACKQDLLAYLQRIALYCHQLNICSKVKAEVQNLGGELIVSGLDSATSLIQAAKNLMNAVVLTVKA...................................................................................................................................................................................................................................................................................... |
818 |
| 38 | -10.600 | PF00261.15; Q805C4_TAKRU/12-248; Tropomyosin |
ali follow.. |
12 | 3 | ...........................................................................................................................IQTLQQQADDAEDRAQVL------QRQLDSERELREKAEGEVAALN---RRIQLVEEELDRAQERLAVALQKLEEAEKAADESERGMKVIE-----NRAMKDEEKMEIQEMQLKEAKHIAEEADRKYEEVARKLVILEGELERAEERAELSECKASDLE-----EELKNVTNNLKSLEAQAEKYSEKEDKYEEEIKILTDKLKEAETRAEFAERTVTKLEKSIDDLEEKLSSAKEENLGMHQVLDQTLLELNSL............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
237 |
| 39 | -10.500 | PF03207.8; Q44722_BORBU/1-254; Borrelia outer surface protein D (OspD) |
ali follow.. |
11 | 3 | ...............................................................................................................KLIKILLLSLFLLLSISCVHDKQELSSKSN------LNNQKGYLDNEGANSNYESKKQSILSELNQLLKQTTNSLKEAKNTTDNLNASNEANKVVEAVINAVNLISSADQVKSAQKNMHDLAQMAEIDLEKIKNSSDKAIFASNLAKEAYSLTKAAEQNMQKL-------EQQKISESESESDYSDSAEIKQAKEAVEIAWKATVEAKDKLIDVENTVKETLDKIKTETTNNTKLADIKEAAELVLQIAKNAKEIVQEV...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
251 |
| 40 | -10.500 | PF12532.3; B3QEB7_RHOPT/422-613; Protein of unknown function (DUF3732 topsan) |
ali follow.. |
12 | 1 | ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ELISKLESEIEDLTVPPI---------NERQELFTSALDEAIQDYISLTRDALGNYGEYRSAFNYSEKKLHL----RKPRTASTENVGSSSN--LHLFLFLGIHELIMRNNGHVALIIDQFSRPYDVAKVKLALELLNQFGKDFQIIVFEH..................... |
167 |
| 41 | -10.400 | PF04849.8; Q4SVU4_TETNG/101-401; HAP1 N-terminal conserved region |
ali follow.. |
8 | 1 | ...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EYICLPSHGGKAKEVEEEEMDEEQQIGRSSMTTKLLWLKFLRVLCADRVGQMTKTYSDIDAVTRLLEEKERDLELAARIGQSLLKKNKALSRNDLLEEQVEHIREEVSQLRHDLSMKDELLQFYTNAAE-ESEGESFTSTPVRPADSNVSTPTFFPLDSLQKKLKDLEEENKSLRSEASHLETETISYEEKEQQLVH-----------DCVKELRNSNLQITSLSEELARKSDDASRQQEEITHLLSQIVDLQKKVKLHALENEELTQHLGAAKDAQRQLTAELRELED--KYAECMEMLHEAQEELKNLRNK............................................................................................................................................................ |
300 |
| 42 | -10.400 | PF04310.7; MUKB_ECOLI/1-227; MukB N-terminal |
ali follow.. |
13 | 32 | LSGGNGAGKSTTMAAFVTALIP--DLTLLHFRNTTEAGATSGSRDKGLHGKLKAGVCYSMLDTINSRHQRVVVGVRLQQVAGRDRKVDIKPFAIQGLPMSVQPTQLVTETLNERQA-------VLPLNELKDKLEAMEGVQFKQFNSITDYHSLMFDLGIIARRLRSASDRSKFYRLIEASLY---GISSAITRSLRD.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
219 |
| 43 | -10.300 | PF10234.4; A7SE98_NEMVE/14-284; Clusterin-associated protein-1 |
ali follow.. |
9 | 5 | .......................................................................................YPRLISMENAEVLIWLVKRYDPNVELPMDVETEQDRVLFIKAVAQFMATKAHIKLNTKKLYGADGYAVKELLKVTSVLYNAKSNVTDDEAEPSDVTSLTFDISSRISDLKASRQLASEIT---------TRGAALYDLLGHEVELRDIRTRAIAKPLEVNELENGIKKSISLAQDDIRKTTQMLDNIASDEANLE-----AKIDKKKQELERNQKRLRSLESVRPAFMDEYEKLEEE---------------------LKKVYETYMEKHRNLSYMEQLLDDVNRAEQDRFE............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
271 |
| 44 | -10.200 | PF06637.6; PLVAP_HUMAN/1-442; PV-1 protein (PLVAP) |
ali follow.. |
8 | 48 | ..........................................................................................VYGNVHVSTESNLQATERRAEGLYSQLLGLTASQSNLTKELNFTTRAKDAI------MQMWLNARRDLDRINASFRQCQGDTNNQRYMAAIILSEKQCRDQFKDMNKSCDALLFMLNQKVKTLE--VEIAKEKTICTK-ESVLLNKRVAEEQLVECVKTRELQHQERQLAKEQLQKVQALCLPLDKDKFEMDLRNLWRDSIIPRSLDNLGYNLYHPLGSELASIRRACDHMPSLMSSKVEELARSLR------ADIERVARENSDLQRQKLEAQQGLRASQEAKQKVEKEAQAREAKLQAECSRQTQLALEEKAVLRKERDNLAKELEEKKREAEQLRMELAIRNSALDTCIKTKSQMMPVSRPMGPVPNPQPIDPASLEEFKRKILESQRPPAGIPVAPSS............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
441 |
| 45 | -10.200 | PF13870.1; B4J5C0_DROGR/499-675; Domain of unknown function (DUF4201 topsan) |
ali follow.. |
10 | 1 | ..................................................................................................................................MSQKRNEISDD------RLYLISRKHTLGRITDKITKLEQINEDLC--MDDFINIQNQVAALDKKIEERNNDLKKLRLNYH-----TELHLTQHNREKALALDSKLDVAKLNLEIMQKKQDQLRECLYKAKLERSNIRKVHSDLSFQGGLLSMPALMFDYDETVERVRAKQASVKELKETFKHITQRILE........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
177 |
| 46 | -10.200 | PF10481.4; CENPF_HUMAN/1-288; Cenp-F N-terminal domain |
ali follow.. |
9 | 10 | ...................................................................................................................................................EGLPTRALQKIQELEGQLDKLK---KEKQQRQFQLDSLEAALQKQKQKVENEKTEGTNLKRENQRLM-----EICESLEKTKQKISHELQVKESQVNFQEGQLNSGKKQIEKLEQELKRCKSELERSQ------------QAAQSADVSLNPCNTPQKIFTTPLTPSQYYSGSKYEDLKEKYNKEVEERKRLEAEVKALQAKKASQTLPQATMNHRDIARHQASSSVFSWQQEKTPSHLSSNSQRTPIRRDFSASYFSGEQEVTPSRSTLQIGKRDANSSFFDNSSSPHLLDQLKA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
285 |
| 47 | -10.100 | PF12004.3; A5PF29_DANRE/580-1085; Domain of unknown function (DUF3498 topsan) |
ali follow.. |
8 | 356 | ...........................................................................................................................................................TAAWLMNVPYIEQEPETELCRDEHTQAEKYQAEISMLQDRLRMSVQRLEEYEARLK-----GQEEQAQKMLLEYARLDESEERLRRQQEDKDLQMKGIISRLMSVEEELKKDHADMQAVSKQKIIDAQEKRIASLDAANARLMSALSQLKER..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
505 |
| 48 | -10.100 | PF10146.4; Q17IP3_AEDAE/14-270; Zinc finger-containing protein |
ali follow.. |
10 | 1 | ...........................................................................................................................................................EAMKDIRSKTLQLEKVKLKIIREVENGDAEEKCLSEYRRELELLMQEKMSHV---------EELRQIHADINAME----------TVIKQAEENRIRSINMANRFHEEYVPLKTEVDTMRREYLGLERLPELHEEEGSIISPDRFQNYYTGSKALTAPTAAFARP........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
146 |
| 49 | -10.100 | PF08317.6; Q754X4_ASHGO/431-759; Spc7 kinetochore protein |
ali follow.. |
11 | 73 | ...........................................................................................................................VKELHRRILDSQRLFQELEEQISNNPPFRNYFESSDEVKQLMKEQIVLIKSFARLEAKKVWFEWRCQHLKGIKSVLEENLSLVQ---------TEYAEVVARLNEISDI----HRLQALEQSLRHELELLRNGEKPMRVTTLADRLKIEKI--KSELKANMIKLNNTANLEEQKEAISADINALRSQIKDVREEISSLKSLVLKNKLHTAHDVSKLRLLFSQMQLF........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
287 |
| 50 | -10.000 | PF10186.4; B2WCB9_PYRTR/2-373; UV radiation resistance protein and autophagy-related subunit 14 |
ali follow.. |
9 | 23 | .......................................................................................................................................................AYLEHPRIELAKTLIDLDGVEKHVKAIINGSEDKAIQHVSLTDSKGGLLVDRQECTNNLNWQRTKAETAEIQERLGNIS----------DHAHQLRQQMEATRKLLEAKRAANAQRKSDLSSATYG-----ESRRANELDKVQQKVKRLDYNADKMHHDTIDLRMQLCTTAAKLAGLKMQRRKTRDGGVKEVFNIGPGSRLRIYDLRDMNDVAPD.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
223 |
| 51 | -9.910 | PF01496.14; VATM_DICDI/30-807; V-type ATPase 116kDa subunit family |
ali follow.. |
7 | 1 | .................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VDELGKLGLIQFLDDNEHVNLFQRNFVNEVKRCDDMEKKLKFFEDQVKKEPKLQKLLPDNMLSVVDDDSQMDELEGRFDELESELKQVNANQETLQRNYNELIQLRHVLTKDSVFFQENPNLIEGEGHEH------------SARSPLLAEDQHVSEVAKQGVKLGFITGVMNTDKMPQFQRSLWRTTRGNNYVKDARIEEEIIDPQTGEETAKTVFIVFFQGERLQQKIKKICESFGANIYDSFERSNLLQKVTVRITDLYEVLQRSKDHKRQTLAGIVPLYSWKKKVLLEKSIYHTKDKIEEIQLALRTATTR------SGALVPSVLSIIKTEGSPPTHFETNKYFQEIVN-HYREV------NPAVL----------------------TIVTFPFLFGVMFGDVGHGALLLL--LISLEKKLAGKKLNELIQMPFDGRYVLFLM...................... |
437 |
| 52 | -9.880 | PF04156.9; Q50FQ1_CHLTR/23-216; IncA protein |
ali follow.. |
7 | 68 | .........................................................................................................................................................................................LHLYQDLQREVGSLKEINFMLS---------VLQKEFLHLSKEFATTSKDLSAVSQDFYSCLQGFRDNYKGFESLLDEYKNSTEEMRKLFSQEIIADLKGSVASLREEIRFLTPLAEEVRRLAHNQQSLTVVIEEL....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
194 |
| 53 | -9.790 | PF13304.1; B1HP30_LYSSC/55-363; AAA domain |
ali follow.. |
19 | 238 | .............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................INWTMDSKGTVRMLHLACVM--VDAYNKGK----IFIDEFDTAFHVSICEFLMAIMNSKRNTSQFVVTSHEIELLD............... |
309 |
| 54 | -9.770 | PF04111.7; YDKA_SCHPO/121-497; Autophagy protein Apg6 |
ali follow.. |
7 | 10 | ........................................................................................................DLLSSKTKVDHPL------VECAELLTEEMSKTLRAL---KEEKKMYFNYDNFLSSQTVHEENTAALDSEIDELMKQINEKEEKIEEISDETDKLQKLLRELD---------EEKEKVYAEEQEF----------YNNLNQFQIKKLSLERQYDCANLEFEHNSRKLEKLQKMNVFSDIFYISHYSEPNGEGSIATINGLRLGRLPSQKVNWA........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
195 |
| 55 | -9.760 | PF06008.9; P70570_RAT/237-496; Laminin Domain I |
ali follow.. |
9 | 16 | .......................................................................................................RHVEMQAKDLRNQLLGFRSAISSHGSQMDGLEKELSHL------YQEFETLQEKAQVNSRKAQTLY---NNIDTTIQNAKELDMKIKNILTNVHILLKQIARPGGEGMDLPVGDWSRESAEAQRMLRELRG--RDFKKHLQEAEAQKMEAQLLLNRIRTWLESHQVENNGLNIRDSLNDYEAKLQDLRSVLQEAAAQGKQATGLNHENEGVLGAIQRQMKEMDSLKKYLTEHLATADASLLQTNSLLQRMDTSQ................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
260 |
| 56 | -9.750 | PF03904.8; YP2A_STAAU/1-230; Domain of unknown function (DUF334 topsan) |
ali follow.. |
7 | 2 | .....................................................................................................................................................RKGQLIMSMKDIKNNKENPN---TQMNSKSTGTPSSSTQNSLNNEELSELKRQNKLIVKYLAEIQ-----ENQKIREKEQKEITSELKEATKDFRDKSLKIRNDFVDVLQEKLKHVDTEELKDILGRGIYKVR-----EENDRMLQEVKRSHEHYQTRQKYLFTGIGAMLLVFMLFA.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
165 |
| 57 | -9.630 | PF06409.6; A6NCT9_HUMAN/1-331; Nuclear pore complex interacting protein (NPIP) |
ali follow.. |
7 | 50 | ..............................................................................................................................................RSYKFAISLCTSYLCVSFLKTIFPSQNGHDGSTDVQQRARRSNRRRQEGIKIVLEDIFTLWRQVETKVRAKICKMKVTTKVNRHDKINGKRKTAKEHLRKLSMKEREHGEKERQVSEAEENGKLDMKEIHTYM------------EMFQRAQALRRRAEDYYRCKITPSARKPLC........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
212 |
| 58 | -9.620 | PF13805.1; C5DXD8_ZYGRC/1-270; Eisosome component PIL1 |
ali follow.. |
11 | 53 | ...........................................................................................................DLARKLSQLVSTEKGVLRSLEVVAYERRAAARQLSLGVDNDDDVSDVTDKLGVLIFELGELQDQYDQYRVTLKSIRNIEASVQPTRNRKEKITDEIAHLKYKDPH---------------------------SPKIPVLEQELVRAEAESLVAEAQLSNITRERMK-ELAEKFALIAGYGKALLELLDDSPVTPGETRSAYDGYDASKQIIMDAEAALE.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
259 |
| 59 | -9.570 | PF10088.4; B2UCR3_RALPJ/445-574; Uncharacterized protein conserved in bacteria (DUF2326 topsan) |
ali follow.. |
9 | 37 | ...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SSGKKQGEISCFDIAYTLFADDENIPCMFLLNDKKELMHDNQLLKIANLVEREKTHIQFVASMLRDKL----PELNSDNFIVLKL |
119 |
| 60 | -9.560 | PF14362.1; D3CY45_9ACTO/50-394; Domain of unknown function (DUF4407 topsan) |
ali follow.. |
8 | 89 | ................................................................................................................LAILIGVVISTPLVLRIFEAEITTELSLMRSERDSTTQTDERGMRIKALEAEQKTLQATIDT--STDTVDVSTDPDVARIQKLVDTKQQQYDAAE------------QAVICENEGTCG--SGKVGRGPAYAEKVALRDRYRDELSVLNGQLTTAQATARSKATDTRGAAQNTAKGRLKTVETELTDLRTARTAAIANFRKENGKENGLLIRIE.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
290 |
| 61 | -9.510 | PF09738.4; LRRF2_BOVIN/31-326; Double stranded RNA binding protein (DUF2051 topsan) |
ali follow.. |
11 | 3 | ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ARLAAKRAARAEARDIRMRELERQQKELDEKSDKQYAENYTRPSSRNSASATTPLSGNSSRRVSGDTSSLIDPDSLSELRESLSEVEEKYKKAMVSNAQLDNEKNNLIYQVD-TLKDVIEEQEEQMAEFYRENEEKSKELERQKHMCSVLQHKMDELKEGLRQRDELIEKHGLVIIPDGTPNG--------DVHQEPAVGAITVVSQEAAQVLESAGEGPLDVRLRKLAGEKEELLSQIRKLKLQLEEERQKCSGRDGTAGDLAELQNGSDLQLI-RDANRQISEYKFKLSKAEQDITTL........................................................................................................................................................ |
296 |
| 62 | -9.480 | PF07058.6; MP704_ARATH/209-559; Myosin II heavy chain-like |
ali follow.. |
9 | 1 | .................................................................................................................................MVDDLQNKNQEL------MKQIEICQEENRIIDKMHRQKVAEVEKLMQSVRELEEAVLAGGAAANAVRDYQRKFQEMNEERKILE-----RELARAKVNANRVATVVANEWKDSNDKVMPVRQWLEERRFLQGEMQQLRDKLAIA--DRAAKSEAQLKEKFLLRLRVLEESLKGPTSSSSRGTSVGRSSSNGPTRRQSLGGAETSPKITSNGSLIK-STVLKHAKGTSRSFDGGTRSLDRSKVLINGPRSNFPLNHKSSEGTSRGESPSSIKGEEESADKATNNDSVPGVLYDLLQKEVITLRKAAHEKD---------QSLRDKDEAIEMLAKKVETLTKAMDVEAKKMRREVAVMGK................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
350 |
| 63 | -9.380 | PF07246.6; Q88304_SFSV/4-294; Phlebovirus nonstructural protein NS-M |
ali follow.. |
13 | 123 | ........................................................................................................................................................DTNDFIRNITTGEQSPRVDYEKLKNAEEKDATIQRKTKEMEEVRAVLDSRNQIAHHEIQQKE--NEIQKLRNDLRDAIKKGQEHESMKLRVEESDARVKGLKEELKQLTYKIFDHQATKDEL---------QHAKSEMQSLRKKIKDFESIPQAKKSSNSSVTLMTTAVLSLLGSSMAA............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
291 |
| 64 | -9.360 | PF05278.7; Q39177_ARATH/434-747; Arabidopsis phospholipase-like protein (PEARLI 4) |
ali follow.. |
10 | 147 | .......................................................................................................QHILQKHGDIASGSKLQSLATRSLASVVFELQTPLKYL--KESRVVEMVAIVKDIESVKIKAGWLKPVLEEIVEAVKHYDEHKMSVVEKEVWERDVLLAKQETEKQVK---------ELGEKEKKIKEWRAKMTEMAAKLGDLDMKRARLHKSFTFLSSKVDQVSKGNPFFKA.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
314 |
| 65 | -9.260 | PF09763.4; EXOC1_DROME/186-866; Exocyst complex component Sec3 |
ali follow.. |
11 | 1 | ..............................................................................................................NELGKLFSECDFAIKDAEQFIEQLSRELHDL-----DGANMQSVLASEQKVLKMMEHIDNAISEADKFENRLDSYEDILGHVKETMEKIGGKNAMIE---------IANNNNIKLMKELNKVISQLDLPHSQQQALDEPDLKTANGRKAAIAAAQCLQQAMNSDIDPA-----LLRLEAVQDQRKRFEKWKQKFSATVSR.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
181 |
| 66 | -9.260 | PF05276.9; Q4SIQ7_TETNG/16-252; SH3 domain-binding protein 5 (SH3BP5) |
ali follow.. |
15 | 1 | .............................................................................................................................EEEEVDPRIQGELEKL---NQSTDDINRWESELEDGRQRFRAVLVEAMC-DGLMKRIGRAVDDSKPYWEARKVAKQAQIEAQKATQEFQRSVEILRAAKETIALAEERLLEEDSRQFDSAWQEMLNHATQRVMEAEQSRTRSEAEHKKT--AANYNSSISHMRQLEKKLKRSINKSRPYFELKGKYYLQLEHLKILVNERQ-----------------AKLMSAKAEYRKALRNLESISEEIHAQRRSVAMGTRE............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
234 |
| 67 | -9.220 | PF12718.2; A6R7T4_AJECN/7-149; Tropomyosin like |
ali follow.. |
9 | 1 | ............................................................................................................................................................KMNTLRLEADDAH---AKVEELQNKVKALEQENLAKEQEIKSLTHRNQLLE---------ADVEKLEADLKDAKASASENAQHGTQNESLQRRLQLLEEEAEETDKTLRETNEKLRQT--DVKAGHYERKVQALETSRDQWEAKYEQMSKKYEDLQK............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
143 |
| 68 | -9.190 | PF05478.6; Q7Q6R9_ANOGA/26-846; Prominin |
ali follow.. |
8 | 160 | ........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SYMQHGVENITTSARHGVHDTRLYLQTTSAHIDHVLNKNYQELNNDLKQLLHDASDNIIKRLEEESK-----AEKLTTLYEFVEKLPGIKGSLEKMKQLTSELRITASQLNDGLRGVKRELLTSLNKCGTQECIKVMDDYKI-GRLNVNGIDYNSLPDLSQIIESVKQLTDSSLGSAIHQGVDQMNELKSTLRQTQNIPKVQAASDSTGKAIKDVSNMLTSRLNNVADTLGNNSYKHLDTADEYIEQDPANDQIINYLDQFVDLNRLYADLAQAERSRTKLQVSEQVEPVHIGEVIVACQQNETIYKVLKLNNFIDIRTIRDFPEHYGITRELAALKEKIKIQSVQILTPEATEDIRALQESKLNDFDVDKFTDNLTFNITEYNLNEIADKLREVANRVPSGKEMNDIKVNLKNQALHLSSYQTNLVDPMIASTNELIKLSTTLDTSLKFGEKSFSA-----AIDKFLTQIKDAEEYINKY---------GKTFVQNVTEELVSGFNNQIHSYITLVIESTEGGLCGPVYNVYESVIVAS-----------VDPFNG-----FWAGVVWCLL---------LPSII-----------GVKLSTLYQKSDPYPGPMV........................ |
821 |
| 69 | -9.160 | PF14073.1; CEP57_HUMAN/68-245; Centrosome localisation domain of Cep57 |
ali follow.. |
11 | 1 | ....................................................................................................................................AIFSALKNL------QDKIRRLELERIQAEESVKTLSRETIE-KVLDEQIQERENSKNEESKHNQELTSQLLAAENKCNLLE-----KQLEYMRNMIKHAEMERTSVLEKQVSLERERQHDQTHVQSQLEKLDLLEQEYNKLTTMQALAE-----KKMQELEAKLHEEEQERKRMQAKAAELQTGLETNRLIF................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
178 |
| 70 | -9.140 | PF12795.2; Q3KJ67_PSEPF/35-273; Mechanosensitive ion channel porin domain |
ali follow.. |
10 | 1 | .......................................................................................................................................ASLDKLTDSKLPEADKKALQTVLQNTLNQLNNRRDYEQKLIDLKQQLATAPKQTIENSRELTRLKASAVVPVAQRFPKENIQQLEQLTERSTQQSDLQKALADANSLIITAQTRPERAQAEISSSQTRIQQINNILKTGKDAGKTVSAEQR-AELAALNALIPLRRQELAGNNQLQDLGNSQHDLLSEKSDR----------------REIQELQTLINQKRLTLSQETVTQQSIEAQKSGSSALLAT......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
238 |
| 71 | -9.070 | PF13851.1; GAS8_HUMAN/220-420; Growth-arrest specific micro-tubule binding |
ali follow.. |
10 | 2 | ................................................................................................................................TLMQRHEEAFTDI--KNYYNDITLNNLALINSLKEQMEDMR---KKEDHLEREMAEVSGQNKRLADPLQKAREEMSEMQKQLANYE--RDKQILLCTKARLKVREKELKDLQWEHEVLEQRFTKVQQERDELYRKFTAAIQEVQQ-VLERKLQALSAAVEQFNEVLAASNLDPAALTLVSRKLEDVLESKNSTIKDL................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
201 |
| 72 | -9.060 | PF09755.4; A0AUQ3_DANRE/3-319; Uncharacterized conserved protein H4 (DUF2046 topsan) |
ali follow.. |
12 | 1 | ........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ADSASESDTDGATPHCSSSSSSSILISSFRLEELSNRLASLQQENKVLKIELETFKLKCKALQEENRDLRKASVTIQARQEEEFISNTLFKKIQALQKEKETLAVNYEKEEEFLTNELSRKLMQLQHEKAELEQHLEQQEFQVNKLMKKIKKLENDTISKQLTLEQLRREKIDLENTLEQEQEALVNRLWKRMDKLEAEKRILQEKLDQPVSAPPSPRDTISMEIDSPENMMRHIRFLKSEVERLKKNLRTSELQHTEKRAQYIE-----EERHMREENIRLQRKLQREVERREALCRQLSESESSLEMDDERYFNEM.................................................................................................................................. |
316 |
| 73 | -9.050 | PF13555.1; Q0A6A1_ALHEH/19-80; P-loop containing region of AAA domain |
ali follow.. |
22 | 28 | LTGDIGSGKSTLVDAITTLLVPAQRIT............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
54 |
| 74 | -9.000 | PF06785.6; Q5L4N7_CHLAB/1-401; Uncharacterised protein family (UPF0242 topsan) |
ali follow.. |
9 | 5 | ....................................................................................................................................................KKIFHPIARYHNYLFPIVAFLLPLVCLPFLSNSQKKYSYFVFSIISLVGWFFSIGLREKQLKT-----AAGQLLQTKIRKIIEKDEGLRKICESVEERQYESQQLRSQNQKLLNQLLHVRGVFMKTKSDMQKLE-----GLVAHLREENQCLQLQLDALSQECREKEEESRELNRELA-----------------EALAYQQVLNEEYQATFTEQHNMLDVRQVYIGKLESKVQDLMCEIRNLLQLESNIVENLPRHAIATSQELPKQLLSELKKIAFKMENIEAASSLTA---------SRYIRSESSVYNYSLECRQLFDNLREENLGMLFVYAPQSQ................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
308 |
